Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status:
Completed
Trial end date:
2018-06-27
Target enrollment:
Participant gender:
Summary
RATIONALE: Lenalidomide and dexamethasone may stop the growth of multiple myeloma by blocking
blood flow to the tumor.
PURPOSE: This phase II trial is studying how well lenalidomide works with or without
dexamethasone in treating patients with newly diagnosed multiple myeloma.